DANIEL STEPHENSON: Open Payments
NPI 1972194926 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,132 in 48 payments from 11 companies in 2025. Trend: 2023 $284 · 2024 $1,188 · 2025 $1,132
Food & beverage: $1,115Education: $17
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 14 | $447 |
| AstraZeneca Pharmaceuticals LP | 8 | $186 |
| Fresenius USA Marketing, Inc. | 11 | $155 |
| Otsuka America Pharmaceutical, Inc. | 5 | $119 |
| AKEBIA THERAPEUTICS INC | 3 | $82 |
| SCPHARMACEUTICALS INC. | 2 | $47 |
| Lilly USA, LLC | 1 | $24 |
| Aurinia Pharma U.S., Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| OPKO Pharmaceuticals, LLC | 1 | $17 |
Products named: IBSRELA, FARXIGA, VELPHORO, XPHOZAH 30 MG, JYNARQUE, Vafseo, FUROSCIX, Auryxia.
Industry payments across VA — which companies pay providers there.
